GEIS, within the framework of its strategies to stimulate and promote the development of translational research projects in sarcomas, launches a new call, the "17th GEIS JOSÉ Mª BUESA SCHOLARSHIP for Research in SARCOMAS". The objective is to have original proposals for research projects that revert to the advancement of clinical therapeutics and a better understanding of sarcomas.
The purpose of this call is to award a Scholarship for an original translational research project in the field of Sarcomas, which will be developed in a national center.
SPANISH GROUP OF RESEARCH IN SARCOMAS, with the collaboration of FMPJC, VYDA, APSATUR Y ASARGA, in its commitment to research and support for new projects will finance a scholarship. The amount will be €15,000 and € 1,000 for indirect expenses.
The economic endowment will be awarded to the person and/or the winning team, or to the managing entity that they request, and will be used to carry out the winning research project.
To participate in this Call, applicants must meet the following requirements:
-
The candidate must have a bachelor's degree or degree in Medicine and Surgery, specialized in one of the following medical areas: Medical Oncology, Radiation Oncology, Pathological Anatomy, Orthopedic Surgery, Plastic Surgery, Thoracic Surgery, General Surgery and other medical specialties related to sarcomas. You could also apply for scholarships for Graduates in Biology, Biochemistry or Pharmacy. Candidates must be linked to a healthcare center
-
. The specific work that is presented must start at the moment in which the aid will be granted and will have a maximum term of 2 years for its execution.
-
The scholarship period will be 24 months.
-
The candidate must be a member of GEIS at the time of the publication of the Call for the Scholarship to which they aspire.
-
The candidate must be registered for the annual GEIS Symposium. In situations of justified cause, and having notified the Technical Secretariat at least 15 days prior to the date of the Symposium, a previously identified member of your team will be allowed to represent you at the Symposium.
-
) The Project may be co-financed by other additional scholarships and/or research projects, provided that the first awarded, chronologically speaking, is the José Mª Buesa scholarship.
-
Each principal investigator may only compete with one project.
-
The researcher will not be able to present his/her candidacy if he/she is part of the same research team awarded previously with these scholarships, regardless of his/her role within said team, until two years have elapsed since the scholarship was awarded in the previous call.
Requests to participate in this call must be sent by email to: This email address is being protected from spambots. You need JavaScript enabled to view it.
The submission deadline is September 1, 2023. Late applications will not be accepted.
Along with the application letter, applicants must submit the following documentation that will be included in the application form available on the GEIS website:
-
Title and Summary of the project (maximum 1 page)
- Project report (maximum 5 sheets) with the following sections:
- Introduction (background of the proposed research project)
- Project objectives
- Material and method
- Statistical plan
- Utility of the project
- Chronogram Breakdown budget / concept of expenses
- Bibliography
-
Photocopy of the DNI
-
Curriculum of the main researcher (the applicant for the Grant)
-
Experience of the Research Group in the last 5 years (maximum 1 page)
-
Description of the research center chosen to carry out the project and available technical facilities (maximum 1 page)
-
Any other information that the applicant considers appropriate to include (maximum one page)
If the application provided is incomplete or does not meet the requirements of this call, the applicant will be given a maximum period of ten days to correct the defects or provide the missing documentation. If you do not do so within the term, the application will be considered withdrawn, which will be archived without further processing.
All documentation submitted to GEIS will be filed in your possession. GEIS guarantees the confidentiality of the documentation.
The Jury will be made up of 4 people: 2 external members with a basic profile and translational oncology and 2 members of the board or outstanding active members of GEIS who will in turn rotate to avoid conflicts of interest with the projects presented. These last two internal members of the jury will be in charge of monitoring the development of the project during the maximum 2 years for its execution.
The score of the works will follow the pattern: Principal Investigator and his team (10 points) + project report (20 points) + clinical application (10 points).
The jury's decision is final.
The GEIS Scholarship may be declared void.
External jury: Marcos Malumbres and Rosa Guerrero López
The jury's decision will be officially communicated during the annual GEIS Symposium on October 6,2023.
The first business day after the Symposium, the award of the aid will be notified in writing. The applicant will also formalize his acceptance in writing.
NOTE: YOU CAN SIGN A COLLABORATION AGREEMENT, CONTRACT WITH THE MANAGING ENTITY (FOUNDATION OR CENTER) FOR THE FINANCIAL MANAGEMENT OF THE PROJECT. IF IT GOES TO MANAGE THE SCHOLARSHIP BY ONE OF THESE ENTITIES, THE MANAGER MUST SIGN THE APPLICATION FOR THE BASES OF THE CALL
The amount will be established as follows:
-
50% of the total at the time of project approval
-
45% of the total prior detailed report after half of the execution time of the project (prior presentation and evaluation of report in the first year)
-
- 5% of the total at the end of the project and presentation of the final report
The awarded projects must become a GEIS project, thus participating the Group in the publications that derive from it and in later stages of development.
The scholarship has the financial collaboration of the Mari Paz Jiménez Casado Foundation (FMPJC), the Spanish Association of People Affected by Sarcoma (AEAS), the Voice and Diffusion Association of Angiosarcoma (VYDA) and the Association of People Affected by Sarcoma of Aragon (APSATUR). ). We thank you for your active support of sarcoma research in particular, as well as your commitment to helping patients as your main reason for being.
The winner will send a detailed report halfway through the execution time of the project (annual report) and at the end of it a final report. These reports must include publications in magazines and communications to national and international congresses derived from the development of the project. Scholarship recipients must commit to presenting the data derived from their analyzes to congresses such as ASCO, CTOS or ESMO. They will also undertake to try to publish the conclusions of their analyzes in high-impact biomedical journals. All the documentation generated from the study (intermediate and final reports and publications) will be shared with FMPJC, AEAS, VYDA AND APSATUR for their information.
The Prize does not imply any contractual relationship between the awardee and the awarding entity (GEIS).
The award-winning applicants will sign an agreement with GEIS that will regulate the details regarding the destination and management of the Scholarship.
The researchers, in any oral or written communication and/or publication about the results obtained in the awarded project, must cite GEIS as the responsible entity and thank FMPJC, AEAS, VYDA AND APSATUR for their support of the project.
Participation in this call implies acceptance of these rules.
José María Buesa was born 1949 November 25th on Jaca (Huesca). He studied Medicine on Zaragoza University and finished his residence on internal medicine on the General Asturias Hospital on 1978, one of the foremost active centers of that moment. During his residency he went through the Oncology Service that was starting its labor.
Convinced of where he wanted to go on his career, he got a scholarship to work on the Oncology Laboratory of the National Cancer Institute at the Netherlands. He worked on Utrech and Amsterdam between 1979 and 1980, finishing his Doctor thesis under the tutelage of the professor HM Pinedo. eventually he returned to the General Asturias Hospital, working for the Oncology Service as assistant physician until 1987. On 1988 he moved to San Sebastián, in charge of developing the medical oncology service from his first superior.
He eventually returned to the Oncology Service of the Asturias General Hospital, as Section director. After a while, he got the post of Director of the Research Unit of Clinical Oncology of the Prince of Asturias University Institute. (IUOPA by its Spanish acronym).
Jose María was a strict scientist, committed to his patients and warm with his friends. His style was more akin to sow than to bloom, placing all his efforts in helping the beginners, trying to remain more in the background than in the spotlight.
Although he did make an impact in several oncology areas, it was the sarcoma the one he put more effort in; So, he was a very active membet of the Soft Tissue Sarcoma and Skeletal Tumors Group of the European Organization for the Treatment and Research on Cancer (EORTC by its Spanish acronym), working as one of the main recruiters for the group's clinical trials and directing several studies marked as milestones in the history of medical treatment of sarcoma. This was one of the constants during his professional years: always publishing the results of the studies in which he participated as main researcher or associate. More than 50 journals signed by him bear witness.
In 1994 he founds the Spanish Group of Sarcoma Research (GEIS) alongside Andres Poveda, Antonio Lopez-Pousa and Javier Martin. His goal was and still is to involve the sarcoma specialists from all across Spain in education and research activities, that back then were barely present on international fora and seminars.
Today GEIS hosts dozens of specialists and hospitals and has a regular presence in the sarcoma publications with the largest international impact.
He died in 2007 January 7th from lung cancer. although as an oncologist he was completely aware of the fate that awaited him due to his diagnosis, he kept working till the last moment. He continued attending his patients, went to GEIs meetings and gave finishing touches to the publication of the last GEIS clinical trials that he was able to see. His GEIS companions have an everlasting memory of his humility, his clarity, his commitment, his huge ability to overwork and his rejection of flattery. Every year, we honor his memory on the way we know he would had liked more, promoting a little bit more the advance in the treatment of sarcomas through the Commemorative Scholarship of Oncological Research José María Buesa.
Previous grants: 2021/ 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2009 / 2008 / 2007 / 2006
